Investigations of the role of host controlled peptidoglycan recycling in the regulation of the pea aphid-Buchnera symbiosis

宿主控制的肽聚糖回收在豌豆蚜-Buchnera 共生调节中的作用研究

基本信息

  • 批准号:
    10228362
  • 负责人:
  • 金额:
    $ 1.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-09 至 2020-12-08
  • 项目状态:
    已结题

项目摘要

Project Summary Animals live in close association with bacteria, including both beneficial symbionts and harmful pathogens. Understanding the nuances that enable hosts to respond differently to pathogenic versus beneficial interactions could enable therapies that specifically target pathogens. A fundamental interface between bacterial and animal cells is the bacterial cell wall. In particular, cell wall peptidoglycan (PG) is known to be a key molecule in the infection process, both for pathogens such as Bordetella pertussis and Neisseria gonorrhoeae and also for symbionts such as Vibrio fischeri. In the model symbiosis of the pea aphid, Acyrthosiphon pisum, with its bacterial symbiont, Buchnera aphidicola, key enzymes in the pathway for PG recycling are encoded in the host genome and are known to be specifically expressed in the cells that harbor the symbiotic bacteria, and similar observations have been made in other eukaryotic systems. The focus of this proposal is to test the novel hypothesis that host control of PG recycling is a key mechanism for host regulation of symbiont populations. We will test this hypothesis using novel biochemical and genetic approaches within the pea aphid system. Specifically, we hypothesize that variation in Buchnera abundance between aphids can be explained by differences in the level of host-derived PG gene expression, that the host employs proteins that alter the Buchnera cell wall, and that host control over Buchnera PG recycling establishes stability of Buchnera population sizes. Testing this hypothesis will shed light on how animals domesticate pathogenic bacteria and convert them into symbionts, and, more broadly, will expand our fundamental understanding of microbial interactions with animals, including humans. To define the role of PG recycling in the regulation of symbiosis, we will: 1) investigate whether PG- related host genes play a role in determining Buchnera population size, 2) determine how host PG-related genes interact functionally with the Buchnera cell wall, and 3) demonstrate the relationship between host PG genes and Buchnera regulation in vivo. To test this, we will quantify the differences in PG gene expression levels between aphid genotypes with high versus low Buchnera abundance, characterize how host gene products affect Buchnera PG in vitro, and interrogate PG gene functions in vivo, implementing novel genetic tools for the aphid-Buchnera system. We predict that aphids use PG genes to disrupt Buchnera PG recycling and halt cell division, enabling hosts to control symbiont abundance by negative regulation. Our genome-scale approaches will enable discovery of other potential genetic bases of symbiont control. Results of the proposed work will contribute significantly to our understanding of how animals interact with symbiotic bacteria and, more specifically, how hosts regulate symbionts. These findings may lead to novel drugs targeting bacterial symbionts of insect disease vectors, or to the development of antibiotics that do not harm beneficial symbionts.
项目总结

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Horizontal-Acquisition of a Promiscuous Peptidoglycan-Recycling Enzyme Enables Aphids To Influence Symbiont Cell Wall Metabolism.
  • DOI:
    10.1128/mbio.02636-21
  • 发表时间:
    2021-12-21
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Smith TE;Lee M;Person MD;Hesek D;Mobashery S;Moran NA
  • 通讯作者:
    Moran NA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas E Smith其他文献

Associations between Social Adversities and Chronic Medical Conditions in a Statewide Sample of Individuals in Treatment for Mental Illnesses.
全州精神疾病治疗个体样本中社会逆境与慢性疾病之间的关联。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Michael T Compton;Eric Y Frimpong;Amy Ehntholt;Huilin Zhu;Sahila Chaudhry;Wahida Ferdousi;Grace A. Rowan;M. Radigan;Thomas E Smith;Merrill Rotter
  • 通讯作者:
    Merrill Rotter
Racial and Ethnic Disparities in Health Care Access and Utilization among Medicaid Managed Care Beneficiaries
医疗补助管理式医疗受益人在医疗保健获取和利用方面的种族和民族差异
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    1.9
  • 作者:
    Eric Y Frimpong;Wahida Ferdousi;Grace A. Rowan;Sahila Chaudhry;Hannah Swetnam;M. Compton;Thomas E Smith;M. Radigan
  • 通讯作者:
    M. Radigan
Family Involvement in Psychiatric Hospitalizations: Associations with Discharge Planning and Aftercare Attendance
家庭参与精神科住院治疗:与出院计划和出院护理的关系
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Morgan Haselden;Tom Corbeil;Fei Tang;M. Olfson;L. Dixon;M. Susan;Essock;M. Wall;M. Radigan;Eric Y Frimpong;Rui Wang;Steven;Lamberti;Matthew Schneider;Thomas E Smith
  • 通讯作者:
    Thomas E Smith
Providing Team-Based Mental Health and Employment Services to Non-traditional Clients
为非传统客户提供基于团队的心理健康和就业服务
Barriers to Client Engagement and Strategies to Improve Participation in Mental Health and Supported Employment Services.
客户参与的障碍以及改善心理健康和支持性就业服务参与的策略。
  • DOI:
    10.1176/appi.ps.202200023
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Thomas E Smith;Debra Bury;D. Hendrick;G. Morse;R. Drake
  • 通讯作者:
    R. Drake

Thomas E Smith的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas E Smith', 18)}}的其他基金

Investigations of the role of host controlled peptidoglycan recycling in the regulation of the pea aphid-Buchnera symbiosis
宿主控制的肽聚糖回收在豌豆蚜-Buchnera 共生调节中的作用研究
  • 批准号:
    9468212
  • 财政年份:
    2017
  • 资助金额:
    $ 1.73万
  • 项目类别:
Investigations of the role of host controlled peptidoglycan recycling in the regulation of the pea aphid-Buchnera symbiosis
宿主控制的肽聚糖回收在豌豆蚜-Buchnera 共生调节中的作用研究
  • 批准号:
    9752631
  • 财政年份:
    2017
  • 资助金额:
    $ 1.73万
  • 项目类别:

相似海外基金

The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
  • 批准号:
    10511408
  • 财政年份:
    2022
  • 资助金额:
    $ 1.73万
  • 项目类别:
A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
调查马拉维野生动物中东非锥虫病生态学的“同一个健康”方法
  • 批准号:
    476178
  • 财政年份:
    2022
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Studentship Programs
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
  • 批准号:
    10677879
  • 财政年份:
    2022
  • 资助金额:
    $ 1.73万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10466942
  • 财政年份:
    2021
  • 资助金额:
    $ 1.73万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10296873
  • 财政年份:
    2021
  • 资助金额:
    $ 1.73万
  • 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
  • 批准号:
    10706306
  • 财政年份:
    2021
  • 资助金额:
    $ 1.73万
  • 项目类别:
Reducing and replacing the animal cost of functional genetics in African trypanosomiasis
减少和替代非洲锥虫病功能遗传学的动物成本
  • 批准号:
    NC/W001144/1
  • 财政年份:
    2021
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Research Grant
Development of new drug for African trypanosomiasis based on elucidation of the mechanism of antiprotozoal action by ribavirin.
基于利巴韦林抗原虫作用机制的阐明,开发治疗非洲锥虫病的新药。
  • 批准号:
    21K18230
  • 财政年份:
    2021
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Development of a novel control measure for African trypanosomiasis based on the blocking of lifecycle progression
基于生命周期进展阻断的非洲锥虫病新型控制措施的开发
  • 批准号:
    20K07467
  • 财政年份:
    2020
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Drug-diagnostic co-development in Tropical Medicine, combating Human African Trypanosomiasis
热带医学药物诊断联合开发,抗击非洲人类锥虫病
  • 批准号:
    18KK0454
  • 财政年份:
    2019
  • 资助金额:
    $ 1.73万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了